Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Axon Neuroscience tau antibody program
- Development stage
- Preclinical
- Lead developer
- Axon Neuroscience
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Administration
- Subcutaneous
01
Overview
The Axon Neuroscience tau antibody program is a discovery-stage research initiative focused on the development of a panel of monoclonal antibodies targeting pathological forms of the tau protein. These antibodies are engineered to recognize distinct epitopes, including both phosphorylation-dependent and phosphorylation-independent sites, which are associated with the progression of Alzheimer's disease and various other tauopathies. By binding to these pathological tau species, the antibodies are intended for use in both diagnostic assays and therapeutic strategies aimed at neutralizing toxic tau and preventing the spread of neurofibrillary tangles in the brain. The program is currently in the discovery phase, exploring a variety of specific antibodies to identify the most effective candidates for clinical development.
- Other names
- Axon tau antibody panelAxon tau antibodiesTau antibody program
02
Targets
Tau aggregates (Microtubule-associated protein tau (pathological form))
Beyond the preview
Go deeper on Axon Neuroscience tau antibody program.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Axon Neuroscience tau antibody program.